Variant report

No.	Distal block	Cell Line	Cell type
1	chr5:95014925..95016820-chr5:95031824..95034428,2	K562	blood:
2	chr5:94980512..95018354-chr5:95057997..95080764,228	K562	blood:
3	chr5:95014665..95016501-chr5:95071803..95074239,2	K562	blood:
4	chr5:95014181..95019210-chr5:95064916..95071420,7	K562	blood:

rSNPs within LD-proxies of this variant (count:25)

rs_ID	r²[population]
rs11949257	1.00[AMR][1000 genomes]
rs11951747	1.00[MEX][hapmap];1.00[YRI][hapmap];1.00[AMR][1000 genomes]
rs11952880	1.00[AMR][1000 genomes]
rs11955539	0.92[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs11956137	0.85[YRI][hapmap];0.97[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs11958444	0.85[YRI][hapmap];1.00[AMR][1000 genomes]
rs11959023	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs57268622	1.00[AMR][1000 genomes]
rs58799139	0.92[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs58937956	1.00[AMR][1000 genomes]
rs59564094	0.85[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs61400254	0.87[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs61733083	1.00[AMR][1000 genomes]
rs6870343	1.00[MEX][hapmap];1.00[YRI][hapmap];1.00[AMR][1000 genomes]
rs73147985	1.00[AMR][1000 genomes]
rs73147991	1.00[AMR][1000 genomes]
rs73149618	1.00[AMR][1000 genomes]
rs73149620	1.00[AMR][1000 genomes]
rs73149622	1.00[AMR][1000 genomes]
rs73149644	0.89[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73149647	0.92[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73149655	0.89[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73149668	0.92[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73149677	0.87[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs73149691	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv598955	chr5:94903453-95136019	Flanking Active TSS Weak transcription Strong transcription Enhancers Bivalent Enhancer Genic enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
2	nsv830409	chr5:95006686-95204496	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs11959236	CXCL14	trans	lymphoblastoid	seeQTL

Chromatin state (count:5 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:95009200-95032400	Weak transcription	Adipose Nuclei	Adipose
2	chr5:95009400-95016400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr5:95010400-95018400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr5:95015000-95015200	Enhancers	Skeletal Muscle Male	skeletal muscle
5	chr5:95015000-95040400	Weak transcription	HSMMtube	muscle

Quick Search: